FREDRIC N ESHELMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of FREDRIC N ESHELMAN
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.92 | 1,000 | 36,920 | 8,527,490 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.91 | 1,000 | 36,910 | 8,528,490 | 8.5 M to 8.5 M (-0.01 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.90 | 2,995 | 110,516 | 8,529,490 | 8.5 M to 8.5 M (-0.04 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.89 | 7,283 | 268,670 | 8,532,485 | 8.5 M to 8.5 M (-0.09 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.88 | 2,137 | 78,813 | 8,539,768 | 8.5 M to 8.5 M (-0.03 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.87 | 1,788 | 65,924 | 8,541,905 | 8.5 M to 8.5 M (-0.02 %) |
| Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.86 | 1,452 | 53,521 | 8,543,693 | 8.5 M to 8.5 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.26 | 100 | 3,726 | 8,600,827 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.24 | 300 | 11,172 | 8,600,927 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.23 | 16 | 596 | 8,601,227 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.22 | 84 | 3,126 | 8,601,243 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.21 | 200 | 7,442 | 8,601,327 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.19 | 100 | 3,719 | 8,601,527 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.18 | 100 | 3,718 | 8,601,627 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.17 | 100 | 3,717 | 8,601,727 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.13 | 75 | 2,785 | 8,601,902 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.12 | 125 | 4,640 | 8,601,902 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.10 | 100 | 3,710 | 8,602,027 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.09 | 300 | 11,127 | 8,602,127 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.08 | 200 | 7,416 | 8,602,427 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.07 | 200 | 7,414 | 8,602,627 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.06 | 218 | 8,079 | 8,602,827 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.05 | 569 | 21,081 | 8,603,045 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.04 | 200 | 7,408 | 8,603,614 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.03 | 1,513 | 56,026 | 8,603,814 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.02 | 600 | 22,212 | 8,605,327 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.01 | 600 | 22,206 | 8,605,927 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.00 | 2,900 | 107,300 | 8,606,527 | 8.6 M to 8.6 M (-0.03 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.99 | 500 | 18,495 | 8,609,427 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.98 | 1,900 | 70,262 | 8,609,927 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.97 | 1,228 | 45,399 | 8,611,827 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.96 | 1,372 | 50,709 | 8,613,055 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.95 | 1,100 | 40,645 | 8,614,427 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.94 | 1,700 | 62,798 | 8,615,527 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.93 | 2,870 | 105,989 | 8,617,227 | 8.6 M to 8.6 M (-0.03 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.92 | 1,530 | 56,488 | 8,620,097 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.91 | 541 | 19,968 | 8,621,627 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | S | 37.27 | 200 | 7,454 | 8,600,627 | 8.6 M to 8.6 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.90 | 1,226 | 45,239 | 8,622,168 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.89 | 1,333 | 49,174 | 8,623,394 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.88 | 1,753 | 64,651 | 8,624,727 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.87 | 1,580 | 58,255 | 8,626,480 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.86 | 1,350 | 49,761 | 8,628,060 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.85 | 1,250 | 46,063 | 8,629,410 | 8.6 M to 8.6 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.84 | 1,900 | 69,996 | 8,630,660 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.83 | 2,100 | 77,343 | 8,632,560 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.82 | 1,716 | 63,183 | 8,634,660 | 8.6 M to 8.6 M (-0.02 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.81 | 3,634 | 133,768 | 8,636,376 | 8.6 M to 8.6 M (-0.04 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.80 | 7,650 | 281,520 | 8,640,010 | 8.6 M to 8.6 M (-0.09 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.79 | 5,627 | 207,017 | 8,647,660 | 8.7 M to 8.6 M (-0.07 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.78 | 4,107 | 151,055 | 8,653,287 | 8.7 M to 8.7 M (-0.05 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.77 | 5,544 | 203,853 | 8,657,394 | 8.7 M to 8.7 M (-0.06 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.76 | 6,021 | 221,332 | 8,662,938 | 8.7 M to 8.7 M (-0.07 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.75 | 7,365 | 270,664 | 8,668,959 | 8.7 M to 8.7 M (-0.08 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.74 | 2,736 | 100,521 | 8,676,324 | 8.7 M to 8.7 M (-0.03 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.73 | 2,400 | 88,152 | 8,679,060 | 8.7 M to 8.7 M (-0.03 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.72 | 800 | 29,376 | 8,681,460 | 8.7 M to 8.7 M (-0.01 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.71 | 200 | 7,342 | 8,682,260 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.70 | 100 | 3,670 | 8,682,460 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.69 | 200 | 7,338 | 8,682,560 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.68 | 100 | 3,668 | 8,682,760 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.66 | 100 | 3,666 | 8,682,860 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.65 | 100 | 3,665 | 8,682,960 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.64 | 100 | 3,664 | 8,683,060 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.61 | 100 | 3,661 | 8,683,160 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.58 | 100 | 3,658 | 8,683,260 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.42 | 200 | 7,284 | 8,683,360 | 8.7 M to 8.7 M (0.00 %) |
| Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.39 | 400 | 14,556 | 8,683,560 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.01 | 200 | 6,802 | 8,683,960 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.00 | 500 | 17,000 | 8,684,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.99 | 1,500 | 50,985 | 8,684,660 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.98 | 700 | 23,786 | 8,686,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.97 | 700 | 23,779 | 8,686,860 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.96 | 800 | 27,168 | 8,687,560 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.95 | 400 | 13,580 | 8,688,360 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.94 | 100 | 3,394 | 8,688,760 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.93 | 200 | 6,786 | 8,688,860 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.92 | 100 | 3,392 | 8,689,060 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.89 | 200 | 6,778 | 8,689,160 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.88 | 200 | 6,776 | 8,689,360 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.84 | 100 | 3,384 | 8,689,560 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.82 | 700 | 23,674 | 8,689,660 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.81 | 800 | 27,048 | 8,690,360 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.80 | 612 | 20,686 | 8,691,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.79 | 1,188 | 40,143 | 8,691,772 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.78 | 1,000 | 33,780 | 8,692,960 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.76 | 1,900 | 64,144 | 8,693,960 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.75 | 100 | 3,375 | 8,695,860 | 8.7 M to 8.7 M (0.00 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.74 | 2,400 | 80,976 | 8,695,960 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.73 | 2,702 | 91,138 | 8,698,360 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.72 | 1,398 | 47,141 | 8,701,062 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.71 | 3,100 | 104,501 | 8,702,460 | 8.7 M to 8.7 M (-0.04 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.70 | 500 | 16,850 | 8,705,560 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.69 | 1,692 | 57,003 | 8,706,060 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.68 | 854 | 28,763 | 8,707,752 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.67 | 1,062 | 35,758 | 8,708,606 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.66 | 2,600 | 87,516 | 8,709,668 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.65 | 892 | 30,016 | 8,712,268 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.64 | 900 | 30,276 | 8,713,160 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.63 | 1,100 | 36,993 | 8,714,060 | 8.7 M to 8.7 M (-0.01 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.62 | 2,400 | 80,688 | 8,715,160 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.61 | 4,200 | 141,162 | 8,717,560 | 8.7 M to 8.7 M (-0.05 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.60 | 5,300 | 178,080 | 8,721,760 | 8.7 M to 8.7 M (-0.06 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.59 | 6,290 | 211,281 | 8,727,060 | 8.7 M to 8.7 M (-0.07 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.58 | 5,410 | 181,668 | 8,733,350 | 8.7 M to 8.7 M (-0.06 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.57 | 2,685 | 90,135 | 8,738,760 | 8.7 M to 8.7 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.56 | 1,915 | 64,267 | 8,741,445 | 8.7 M to 8.7 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.55 | 5,200 | 174,460 | 8,743,360 | 8.7 M to 8.7 M (-0.06 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.54 | 6,700 | 224,718 | 8,748,560 | 8.8 M to 8.7 M (-0.08 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.53 | 2,300 | 77,119 | 8,755,260 | 8.8 M to 8.8 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.52 | 1,500 | 50,280 | 8,757,560 | 8.8 M to 8.8 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.51 | 3,664 | 122,781 | 8,759,060 | 8.8 M to 8.8 M (-0.04 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.50 | 2,570 | 86,095 | 8,762,724 | 8.8 M to 8.8 M (-0.03 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.49 | 1,900 | 63,631 | 8,765,294 | 8.8 M to 8.8 M (-0.02 %) |
| May 15 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.48 | 100 | 3,348 | 8,767,194 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.89 | 200 | 7,178 | 8,767,294 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.71 | 100 | 3,571 | 8,767,494 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.63 | 200 | 7,126 | 8,767,594 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.62 | 100 | 3,562 | 8,767,794 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.51 | 100 | 3,551 | 8,767,894 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 34.46 | 100 | 3,446 | 8,767,994 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.36 | 100 | 3,536 | 8,768,094 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.33 | 100 | 3,533 | 8,768,194 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.31 | 100 | 3,531 | 8,768,294 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.30 | 1,400 | 49,420 | 8,768,394 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.29 | 300 | 10,587 | 8,769,794 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.28 | 400 | 14,112 | 8,770,094 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.27 | 700 | 24,689 | 8,770,494 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.26 | 2,300 | 81,098 | 8,771,194 | 8.8 M to 8.8 M (-0.03 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.25 | 4,000 | 141,000 | 8,773,494 | 8.8 M to 8.8 M (-0.05 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.24 | 800 | 28,192 | 8,777,494 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.23 | 3,200 | 112,736 | 8,778,294 | 8.8 M to 8.8 M (-0.04 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.22 | 900 | 31,698 | 8,781,494 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.21 | 400 | 14,084 | 8,782,394 | 8.8 M to 8.8 M (0.00 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.20 | 700 | 24,640 | 8,782,794 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.19 | 1,700 | 59,823 | 8,783,494 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.18 | 1,209 | 42,533 | 8,785,194 | 8.8 M to 8.8 M (-0.01 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.17 | 2,391 | 84,091 | 8,786,403 | 8.8 M to 8.8 M (-0.03 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.16 | 2,700 | 94,932 | 8,788,794 | 8.8 M to 8.8 M (-0.03 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.15 | 2,235 | 78,560 | 8,791,494 | 8.8 M to 8.8 M (-0.03 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.14 | 4,278 | 150,329 | 8,793,729 | 8.8 M to 8.8 M (-0.05 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.13 | 5,791 | 203,438 | 8,798,007 | 8.8 M to 8.8 M (-0.07 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.12 | 5,596 | 196,532 | 8,803,798 | 8.8 M to 8.8 M (-0.06 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.11 | 7,369 | 258,726 | 8,809,394 | 8.8 M to 8.8 M (-0.08 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.10 | 5,231 | 183,608 | 8,816,763 | 8.8 M to 8.8 M (-0.06 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.09 | 1,700 | 59,653 | 8,821,994 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.08 | 1,400 | 49,112 | 8,823,694 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.07 | 2,200 | 77,154 | 8,825,094 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.06 | 1,600 | 56,096 | 8,827,294 | 8.8 M to 8.8 M (-0.02 %) |
| May 02 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 35.05 | 1,100 | 38,555 | 8,828,894 | 8.8 M to 8.8 M (-0.01 %) |